Journal of Diabetology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +447723862070

Diabetic eye disorders and a novel approach via “OPTICORR”

Joint Event International Conference on Diabetes, Endocrinology and Metabolic Syndrome & Annual Summit on Diabetes, Obesity & Heart
March 07-08, 2019 | London, UK

Vinod Chandra Tawar

King George Medical Clinic, Canada

Keynote : J Diabetol


Diabetic eye disorders have been of common occurrence resulting from a progressive uncontrolled disease leading to cataracts and retinopathy. A review of past literature from 2006 to date has demonstrated a common message i.e. utilizations of vitamins for the resolutions of retinal disorders. The researchers in 2006 had shown the effects of retinol as an agent in the treatment of age-related maculopathy. Subsequent studies were focused on Vitamin A supplementation in children for Retinal dysfunction. Our current research from 2015 had one primary objective of creating a topical preparation as an alternative to the oral treatment to escape from systemic side effects. The OPTICORR our innovative formulation was studied in the pilot project and had shown a dramatic improvement restoring to normal vision. The patients were instructed to apply OPTICORR on the eyelids externally for a duration of 12 weeks. A large scale study has been conducted with a target population of 30 patients. The project will be continued for an in determined period due to the encouraging benefits for a duration to normal restoration. In addition, the medication has shown resolution of challenging dermatological diseases. The study was free of any adverse symptoms except for presence of l erythema at the region of the application on the skin would likely indicate intolerance to vitamin ingredients therefore a discontinuation would be warranted.


Vinod Chandra Tawar has earned BSc Hons. and BSc Tech. Pharmaceuticals from University of Bombay. He was offered a teaching assistantship at the School of Pharmacy, University of Manitoba, Canada, where he achieved a Post-graduate (MSc) degree in Pharmacology followed by working as a Toxicologist at a University Hospital in Winnipeg for a duration of 10 years. In due course, he developed a Toxicology laboratory for patient management and Forensic purposes. This later became a reference laboratory for the Province of Manitoba. In 1981, he decided to study Medicine and graduated Medicine in 1985. Subsequently, he joined Douglas Hospital Research Centre at McGill University as a Psychiatry Research Consultant with participation in projects on depression, Alzheimer’s disease, alcoholism and schizophrenia. Currently he is working in King George Medical Clinic, Canada. 


Get the App

Vizag Tech Summit